Bristol Myers' cell therapy Breyanzi, fresh off an FDA nod, eyes earlier lymphoma use with first-in-class win

10th June 2021 Uncategorised 0

Bristol Myers’ cell therapy Breyanzi, fresh off an FDA nod, eyes earlier lymphoma use with first-in-class win
aliu
Thu, 06/10/2021 – 10:01

More: Bristol Myers' cell therapy Breyanzi, fresh off an FDA nod, eyes earlier lymphoma use with first-in-class win
Source: fierce